Prevention of cisplatin nephrotoxicity by exogenous atrial natriuretic peptide 1

Toxicology

Volumn 106, Issue 1-3, 1996, Pages 159-166

  Deegan, Patricia M ^a,b   Basinger, Mark A ^a   Jones, Mark M ^a   Hande, Kenneth R ^a,b  

^a VANDERBILT UNIVERSITY   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Atrial natriuretic peptide; Cisplatin; Nephrotoxicity; Platinum

Indexed keywords

ANIMALIA;

ATRIAL NATRIURETIC FACTOR; CISPLATIN; PROTECTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY FUNCTION; MALE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTINEOPLASTIC AGENTS; ATRIAL NATRIURETIC FACTOR; BLOOD UREA NITROGEN; CARCINOMA 256, WALKER; CISPLATIN; CREATININE; DRUG INTERACTIONS; GLOMERULAR FILTRATION RATE; KIDNEY; KIDNEY DISEASES; MALE; RATS; RATS, SPRAGUE-DAWLEY; RENAL CIRCULATION; SODIUM CHLORIDE;

EID: 0029671174     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0300-483X(95)03182-F     Document Type: Article

References (34)

1. Aamdal, S., Fodstad, O. and Pihl, A. (1987) Some procedures to reduce cisplatin toxicity reduce antitumor activity. Cancer Treat. Rev . 14, 389-395.
2. Akabane, S., Imanishi, M,. Matsushima, Y., Kawamura, M., Kuramochi, M., Ito, K. and Omae, T. (1988) Renal actions of atrial peptide on the postischemic kidney. Can. J. Physiol. Pharmacol. 66, 601-607.
3. Basinger, M.A., Jones, M.M. and Holscher, M.A. (1990) L-Methionine antagonism of cis-platinum nephrotoxicity. Toxicol. Appl. Pharmacol. 103, 1-15.
4. 99mTc. Nephron 24, 174-178
5. Bishop, J.F. (1992) Current experience with high-dose carboplatin therapy. Semin. Oncol. 19, (suppl. 2), 150-154.
6. Blachley, J.D. and Hill, J.B. (1981) Renal and electrolyte disturbances associated with cisplatin. Ann. Int. Med. 95, 628-632.
7. Capasso, G., Anastasio, P., Giordano, D., Albarano, L. and Desanto, N.G. (1987) Beneficial effects of atrial natriuretic factor on cisplatin-induced acute renal failure in the rat. Am. J. Nephrol. 7 , 228-234.
8. Capasso, G., Rosati, C., Ciani, F., Giordano, D.R., Russo, F. and Desanto, N.G. (1990) The beneficial effect of atrial natriuretic peptide on cyclosporine nephrotoxicity. Am. J. Hypertens. 3, 204-210.
9. Deegan, P.M., Pratt, I.S. and Ryan, M.P. (1994) Nephrotoxicity, cytotoxicity and renal handling of a cisplatinmethionine complex in male Wistar rats. Toxicolology 89, 1-14.
10. Dunn, B.R., Ichikawa, I., Pfeffer, J.M., Troy, J.L. and Brenner, B.M. (1986) Renal and systemic hemodynamic effects of synthetic atrial natriuretic peptide in the anesthetized rat. Circ. Res. 59, 237-246.
11. Finn, W.F. (1980) Postischemic acute renal failure. Initiation, maintenance, and recovery. Invest. Urol. 17, 427-431.
12. Goetz, K.L. (1988) Physiology and pathophysiology of atrial peptides. Am. J. Physiol. 254, E1-E15.
13. Harris, P.J. and Skinner, S.L. (1990) Intra-renal interactions between angiotensin II and atrial natriuretic factor. Kidney Int. 38, S87-S91.
14. Hayes, D.M., Cvitkovic, E., Gobley, R.B., Scheiner, E., Helson, L. and Krakoff, I. (1977) High dose of Cis-platinum diammine dichloride. Amelioration of renal toxicity by mannitol diuresis. Cancer 39, 1372-1381.
15. Hutchinson, F.N., Perez, E.A., Gandara, D.R., Lawrence, H.J. and Kayson, G.A. (1988) Renal salt wasting in patients treated with cisplatin. Ann. Int. Med. 108, 21-25.
16. Jones, M.M., Basinger, M.A. and Holscher, M.A. (1991) Relative effectiveness of some compounds for the control of cisplatin-induced nephrotoxicity. Toxicology 68, 227-247.
17. Kato, J., Kida, O., Higa, T., Sasaki, A., Kondo, K., Miyata, A., Kengawa, K., Matsuo, H. and Tanaka, K. (1986) Increase in plasma atrial natriuretic polypeptide (ANP) following sodium load in anesthetized rats. Life Sci. 39, 493-497.
18. Kurnik, B.R.C., Weisberg, L.S., Cuttler, I.M. and Kurnik, P.B. (1990) Effects of atrial natriuretic peptide versus mannitol on renal blood flow during radiocontrast infusion in chronic renal failure. J. Lab. Clin. Med. 116, 27-35.
19. Kurnik, B.R.C., Weisberg, L.S., Askenase, A.D. and Kurnik, P.B. (1991) Mannitol stimulates atrial natriuretic peptide release in humans. Am. J. Kidney Dis. 17, 62-65.
20. Leroy, A.F., Wehling, M.L., Sponseller, H.L., Litterst ,C.L., Gram, T.E., Guarino, A.M. and Becher, D.A. (1977) Analysis of platinum in biological materials by flameless atomic absorption spectrophotometry. Biochem. Med. 18, 184-191.
21. Loehrer, P.J. and Einhorn, L.H. (1984) Cisplatin. Ann. Int. Med. 100, 704.
22. Madias, N.B. and Harrington, J.T. (1978) Platinum nephrotoxicity. Am. J. Med. 65, 704-713.
23. Mason, M.D., Nicholls, J. and Horwich, A. (1991) The effect of carboplatin on renal function in patients with metastatic germ cell tumours. Br. J. Cancer 63, 630-633.
24. Olsen, S. and Solez, K. (1987) Acute renal failure in man: pathogenesis in light of new morphological data. Clin. Nephrol. 27, 271-277.
25. Ormond, P.M., Basinger, M.A., Jones, M.M. and Hande, K.R. (1992) Association between increased atrial natriuretic peptide (ANP) and reduced cisplatin nephrotoxicity in rats. J. Pharmacol. Exp. Ther. 262, 246-251.
26. Ozols, R.F., Corden, B.J., Jacobs, J., Wesley, M.N., Ostchegas, Y. and Young, R.C. (1984) High dose cisplatin in hypertonic saline. Ann. Int. Med. 100, 19-24.
27. Pollock, D.M., Holst, M. and Opgenorth, T.J. (1991) Effect of the ANF analog A68828 in cisplatin-induced acute renal failure. J. Pharmacol. Exp. Ther. 257, 1179-1183.
28. Pollock, D.M. and Opgenorth, T.J. (1992) Beneficial effect of the ANP analog A68828 on recovery from ischemic acute renal failure. Renal Failure 14, 141-146.
29. Rose, W.C., Schurig, J.E., Huftalen, J.B. and Bradner, W.T. (1982) Antitumor activity and toxicity of cisplatin analogs. Cancer Treat Rev. 66, 135-146.
30. Safirstein, R., Winston, J., Goldstein, M., Moel, D., Dikman, S. and Guttenplan, J. (1986) Cisplatin nephrotoxicity. Am. J. Kidney Dis. 8, 356-367.
31. Schor, N., Ichikawa, I., Rennke, H.G., Troy, J.L. and Brenner, B.M. (1981) Pathophysiology of altered glomerular function in aminoglycoside-treated rats. Kidney Int. 19, 288-292.
32. Scott, L.A., Madan, E. and Valentovic, M.A. (1989) Attenuation of cisplatin nephrotoxicity by streptozotocin-induced diabetes. Fundam. Appl. Toxicol. 12, 530-539.
33. Siddik, Z.H., Boxall, F.E. and Harrap, K.R. (1987) Haematological toxicity of carboplatin in rats. Br. J. Cancer 55, 375-379.
34. 131I (conray). J. Nucl. Med. 7, 60-68.